Kenneth Krogulski - 01 Dec 2021 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
01 Dec 2021
Transactions value $
$8,817
Form type
4
Filing time
07 Jan 2022, 16:08:46 UTC
Previous filing
03 Dec 2021
Next filing
29 Apr 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $310 +75 +0.04% $4.14 181,260 01 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $288 +75 +0.04% $3.84 181,335 02 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $335 +75 +0.04% $4.47 181,410 03 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $334 +75 +0.04% $4.46 181,485 06 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $420 +75 +0.04% $5.61 181,560 07 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $461 +75 +0.04% $6.15 181,635 08 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $435 +75 +0.04% $5.81 181,710 09 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $361 +75 +0.04% $4.82 181,785 10 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $872 +200 +0.11% $4.36 181,985 13 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $856 +200 +0.11% $4.28 182,185 14 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $858 +200 +0.11% $4.29 182,385 15 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $1,087 +240 +0.13% $4.53 182,625 16 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $1,000 +240 +0.13% $4.17 182,865 17 Dec 2021 Direct F1
transaction CPIX Common Stock Purchase $1,195 +276 +0.15% $4.33 183,141 20 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.